Celltrion develops tailored neutralising antibody cocktail treatment with CT-P59 to tackle COVID-19 variant spread using its antibody development plat.
Rankings by 
National Ranking
8th
in South KoreaRegional Ranking
30th
in East AsiaGlobal Ranking
811th
worldwide